ArticleEye (London, England)2024

Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study.

Furkan Çam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.